Control of vascular smooth muscle cell growth by connexin 43

Frontiers in Physiology

Volumn 3 JUN, Issue , 2012, Pages

  Joshi, Chintamani N ^a   Martin, Danielle N ^a   Shaver, Patti ^a   Madamanchi, Chaitanya ^a   Muller Borer, Barbara J ^a   Tulis, David A ^a  

^a EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Camp; Cgmp; Cx43; Protein kinases; Vascular smooth muscle cells

Indexed keywords

EID: 84866396322     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2012.00220     Document Type: Article

References (77)

1. Adderley, S. P., Joshi, C. N., Martin, D. N., and Tulis, D. A. (2012). Phosphodiesterases regulate BAY 41-2272-induced VASP phosphory-lation in vascular smooth muscle cells. Front. Pharmacol. 3:10. doi:10.3389/fphar.2012.00010
2. Arunkumar, A., Vijayababu, M. R., Venkataraman, P., Senthilkumar, K., and Arunakaran, J. (2006). Chemo-prevention of rat prostate car-cinogenesis by diallyl disulfide, an organosulfur compound of garlic. Biol. Pharm. Bull. 29, 375-379.
3. Beny, J. L., and Connat, J. L. (1992). An electron-microscopic study of smooth muscle cell dye coupling in the pig coronary arteries. Role of gap junctions. Circ. Res. 70, 49-55.
4. Berthoud, V. M., Ledbetter, M. L. S., Hertzberg, E. L., and Saez, J. C. (1992). Connexin43 in MDCK cells: Regulation by a tumor-promoting phorbol ester and calcium. Eur. J. Cell Biol. 57, 40-50.
5. Bittman, K. S., and LoTurco, J. J. (1999). Differential regulation of connexin 26 and 43 in murine neo-cortical precursors. Cereb. Cortex 9, 188-195.
6. Blackburn, J. P., Peters, N. S., Yeh, H. I., Rothery, S., Green, C. R., and Severs, N. J. (1995). Upregulation of con-nexin43 gap junctions during early stages of human coronary atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 15, 1219-1228.
7. Brisset, A. C., Isakson, B. E., and Kwak, B. R. (2009). Connexins in vascular physiology and pathology. Antioxid. Redox Signal. 11, 267-282.
8. Butt, E., Abel, K., Krieger, M., Palm, D., Hoppe, V., Hoppe, J., and Walter, U. (1994). cAMP and cGMP-dependent protein kinase phospho-rylation sites of the focal adhesion vasodilator-stimulated phos-phoprotein (VASP) in vitro and in intact human platelets. J. Biol. Chem. 269, 14509-14517.
9. Chadjichristos, C. E., Morel, S., Derou-ette, J. P., Sutter, E., Roth, I., Brisset, A. C., Bochaton-Piallat, M. L., and Kwak, B. R. (2008). Targeting con-nexin 43 prevents platelet-derived growth factor-BB-induced pheno-typic change in porcine coronary artery smooth muscle cells. Circ. Res. 102, 653-660.
10. Chen, H., Kovar, J., Sissons, S., Cox, K., Matter, W., Chadwell, F., Luan, P., Vlahos, C. J., Schutz-Geschwender, A., and Olive, D. M. (2005). A cell-based immuno-cytochemical assay for monitoring kinase signaling pathways and drug efficacy. Anal. Biochem. 338, 136-142.
11. Cooper, C. D., Solan, J. L., Dole-jsi, K. K., and Lampe, P. D. (2000). Analysis of connexin phos-phorylation sites. Methods 20, 196-204.
12. Coutinho, P., Qiu, C., Frank, S., Tamber, K., and Becker, D. (2003). Dynamic changes in connexin expression correlate with key events in the wound healing process. Cell Biol. Int. 27, 525-541.
13. Dang, X., Jeyaraman, M., and Kar-dami, E. (2006). Regulation of connexin-43- mediated growthinhi-bitionbya phosphorylatable amino-acid is independent of gap junction-forming ability. Mol. Cell. Biochem. 289, 201-207.
14. Dey, N. B., Foley, K. F., Lincoln, T. M., and Dostmann, W. R. (2005). Inhibition of cGMP dependent protein kinase reverses phenotypic modulation of vascular smooth muscle cells. J. Cardiovasc. Pharmacol. 45, 404-413.
15. Dostmann, W. R., Tegge, W., Frank, R., Nickl, C. K., Taylor, M. S., and Brayden, J. E. (2002). Exploring the mechanisms of vascular smooth muscle tone with highly specific, membrane-permeable inhibitors of cyclic GMP-dependent protein kinase Iα. Pharmacol. Ther. 93, 203-215.
16. Durante, W, Schini, V. B., Catovsky, S., Kroll, M. H., Vanhoutte, P. M., and Schafer, A. I. (1993). Plasmin potentiates induction of nitric oxide synthase in vascular smooth muscle cells. Am. J. Physiol. 264, H617- H624.
17. Evans, W. H., and Martin, P. E. (2002). Gap junctions: structure and function. Mol. Membr. Biol. 19, 121-136.
18. Figueroa,X. F., and Duling,B. R. (2009). Gap junctions in the control of vascular function. Antioxid. Redox Signal. 11, 251-266.
19. Figueroa, X. F., Isakson, B. E., and Dul-ing, B. R. (2006). Vascular gap junctions in hypertension. Hypertension 48, 804-811.
20. Giordano,A., Romano,S.,Mallardo,M., D'Angelillo, A., Calí, G., Corcione, N., Ferraro P., and Romano, M. F. (2008). FK506 can activate transforming growth factor-β signalling in vascular smooth muscle cells and promote proliferation. Cardiovasc. Res. 79, 519-526.
21. Goodwin, J. S., and Kenworthy, A. K. (2005). Photobleaching approaches to investigate diffusional mobility and trafficking of Ras in living cells. Methods 37, 154-164.
22. Haas, T. L., and Duling, B. R. (1997). Morphology favors an endothelial cell pathway for longitudinal conduction within arterioles. Microvasc. Res. 53, 113-120.
23. Haefliger, J. A., Nicod, P., and Meda. P. (2004). Contribution of connexins to the function of the vascular wall. Cardiovasc. Res. 62, 345-356.
24. Huard, C., Druesne, N., Guyonnet, D., Thomas, M., Pagniez, A., Le Bon, A. M., Martel, P., and Chaumontet, C. (2004). Diallyl disulfide (DADS) enhances gap-junctional intercellular communication by both direct and indirect mechanisms in rat liver cells. Carcinogenesis 25, 91-98.
25. Indolfi, C., Di Lorenzo, E., Rapacci-uolo, A., Stingone, A. M., Stabile, E., Leccia, A., Torella, D., Caputo, R., Ciardiello, F., Tortora, G., and Chiariello, M. (2000). 8-chloro-cAMP inhibits smooth muscle cell proliferation in vitro and neointima formation inducedbyballoon injury in vivo. J. Am. Coll. Cardiol. 36, 288-293.
26. Isakson, B. E., Damon, D. N., Day, K. H., Liao, Y., and Duling, B. R. (2006). Connexin40 and con-nexin43 in mouse aortic endothe-lium: evidence for coordinated regulation. Am. J. Physiol. Heart Circ. Physiol. 290, H1199-H1205.
27. Jara, P. I., Boric, M. P., and Saez, J. C. (1995). Leukocytes express connexin 43 after activation with lipopolysaccharide and appear to form gap junctions with endothe-lial cells after ischemia-reperfusion. Proc. Natl. Acad. Sci. U.S.A. 92, 7011-7015.
28. Johnstone, S., Isakson, B., and Locke, D. (2009). Biological and biophysical properties of vascular connexin channels. Int. Rev. Cell Mol. Biol.278, 69-118.
29. Joshi, C. N., Martin, D. N., Fox, J. C., Mendelev, N. N., Brown, T. A., and Tulis, D. A. (2011). The soluble guanylate cyclase stimulator BAY 41-2272 inhibits vascular smooth muscle growth through the PKA and PKG pathways. J. Pharmacol. Exp. Ther. 339, 394-402.
30. Kanemitsu, M. Y., Jiang, W., and Eck-hart, W. (1998). Cdc2-mediated phosphorylation of the gap junction protein, connexin43, during mitosis. Cell Growth Differ. 9, 13-21.
31. Knowles, L. M., and Milner, J. A. (2000). Allyl sulfides modify cell growth. Drug Metabol. Drug. Interact. 17, 81-107.
32. Koo, S. K., Kim, D. Y., Park, S. D., Kang, K. W., and Joe, C. O. (1997). PKC phosphorylation disrupts gap junc-tional communicationatG0/S phase in clone 9 cells. Mol. Cell. Biochem. 167, 41-49.
33. Kumar, N. M., and Gilula, N. B. (1996). The gap junction communication channel. Cell 84, 381-388.
34. Kurjiaka, D. T., Steele, T. D., Olsen, M. V., and Burt, J. M. (1998). Gap junction permeability is diminished in proliferating vascular smooth muscle cells. Am. J. Physiol. 275, C1674- C1682.
35. Kwak, B. R., and Jongsma, H. J. (1996). Regulation of cardiac gap junction channel permeability and conductance by several phosphorylating conditions. Mol. Cell. Biochem. 157, 93-99.
36. Kwak, B. R., Mulhaupt, F., Veillard, N., Gros, D. B., and Mach, F. (2002). Altered pattern of vascular con-nexin expression in atherosclerotic plaques. Arterioscler. Thromb. Vasc. Biol. 22, 225-230.
37. Kwak, B. R., Van Veen, T. A. B., Anal-bers, L. J. S., and Jongsma, H. J. (1995). TPA increases conductance but decreases permeability in neonatal rat cardiomyocyte gap junction channels. Exp. Cell Res. 220, 456-463.
38. Laird, D. W. (2005). Connexin phos-phorylation as a regulatory event linked to gap junction internaliza-tion and degradation. Biochim. Bio-phys. Acta 1711, 172-182.
39. Laird, D. W., Puranam, K. L., and Revel, J. P. (1991). Turnover and phosphorylation dynamics of con-nexin43 gap junction protein in cultured cardiac myocytes. Biochem. J. 273, 67-72.
40. Lampe, P. D., Kurata, W. E., Warn-Cramer, B., and Lau, A. F. (1998). Formation of a distinct connexin43 phosphoisoform in mitotic cells is dependent upon p34cdc2 kinase. J. Cell. Sci. 111, 833-841.
41. Lampe, P. D., and Lau, A. F. (2000). Regulation of gap junctions by phosphorylation of connexins. Arch. Biochem. Biophys. 384, 205-215.
42. Lampe, P. D., and Lau, A. F. (2004). The effects of connexin phosphory-lation on gap junctional communication. Int. J. Biochem. Cell Biol. 36, 1171-1186.
43. Lampe, P. D., TenBroek, E. M., Burt, J. M., Kurata, W. E., Johnson, R. G., and Lau, A. F. (2000). Phosphoryla-tion of connexin43 on serine368 by protein kinase c regulates gap junc-tional communication. J. Cell Biol. 149, 1503-1512.
44. Liao, Y., Regan, C. P., Manabe, I., Owens, G. K., Day, K. H., Damon, D. N., and Duling, B. R. (2007). Smooth muscle-targeted knockout of connexin43 enhances neointimal formation in response to vascular injury. Arterioscler. Thromb. Vasc. Biol. 27, 1037-1042.
45. Lincoln, T. M., Wu, X., Sellak, H., Dey, N., and Choi, C. S. (2006). Regulation of vascular smooth muscle cell phenotype by cyclic GMP and cyclic GMP-dependent protein kinase. Front. Biosci. 11, 356-367.
46. Little, T. L., Beyer, E. C., and Duling, B. R. (1995). Connexin 43 and con-nexin 40 gap junctional proteins are present in arteriolar smooth muscle and endothelium in vivo. Am. J. Physiol. 268, H729-H739.
47. Liu, X. M., Peyton, K. J., Mendelev, N. N., Wang, H., Tulis, D. A., and Durante, W. (2009). YC-1 stimulates the expression of gaseous monoxide-generating enzymes in vascular smooth muscle cells. Mol. Pharmacol. 75, 208-217.
48. Maurice,D.H.,andHaslam,R.J.(1990). Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylatecyclase: inhibition of cyclic AMP breakdown by cyclic GMP. Mol. Pharmacol. 37, 671-681.
49. Mendelev, N. N., Williams, V. S., and Tulis, D. A. (2009). Antigrowth properties of BAY 41-2272 in vascular smooth muscle cells. J. Cardio-vasc. Pharmacol. 53, 121-131.
50. Muller-Borer,B. J., Cascio,W. E., Anderson, P. A. W., Snowwaert, J. N., Frye, J. R., Desai, N., Bagnell, C. R., Cole-man, W. B., Grisham, J. W., and Malouf, N. N. (2004). Adult derived liver stem cells acquire a cardiac myocyte structural and functional phenotype in culture. Am. J. Pathol. 165, 135-145.
51. Nihei, O. K., Fonseca, P. C., Rubim, N. M., Bonavita, A. G., Lyra, J. S., Neves-dos-Santos, S., de Carvalho, A. C., Spray, D. C., Savino, W., and Alves, L. A. (2010). Modula-tory effects of cAMP and PKC activation on gap junctional intercellular communication among thymic epithelial cells. BMC Cell Biol. 11, 3. doi:10.1186/1471-2121-11-3
52. Norris, R. P., Freudzon, M., Mehlmann, L. M., Cowan, A. E., Simon, A. M., Paul, D. L., Lampe, P. D., and Jaffe, L. A. (2008). Luteinizing hormone causes MAP kinase dependent phos-phorylation and closureof connexin 43 gap junctions in mouse ovarian follicles: one of two paths to mei-otic resumption. Development 135, 3229-3238.
53. Paulson, A. F., Lampe, P. D., Meyer, R. A., Atkinson, M. A., Walseth, T. F., and Johnson, R. G. (2000). Cyclic AMP and LDL trigger a rapid enhancementingap junction assembly through a stimulation of con-nexin trafficking. J. Cell. Sci. 113, 3037-3049.
54. Polacek, D., Bech, F., McKinsey, J. F., and Davies, P. F. (1997). Con-nexin43 gene expression in the rabbit arterial wall: effects of hyperc-holesterolemia, balloon injury and their combination. J. Vasc. Res. 34, 19-30.
55. Reinhard, M., Jarchau, T., and Walter, U. (2001). Actin-based motil-ity: stop and go with Ena/VASP proteins. Trends Biochem. Sci. 26, 243-249.
56. Rivedal, E., and Opsahl, H. (2001). Role of PKC and MAP kinaseinEGF- and TPA-induced connexin43 phospho-rylation and inhibition of gap junction intercellular communication in rat liver epithelial cells. Carcinogen-esis 22, 1543-1550.
57. Ruch, R. J., Trosko, J. E., and Madhukar, B. V. (2001). Inhibition of con-nexin43 gap junctional intercellular communication by TPA requires ERK activation. J. Cell. Biochem. 83, 163-169.
58. Saitongdee, P., Becker, D. L., Milner, P., Knight, G. E., and Burnstock, G. (2004). Levels of gap junction proteins in coronary arterioles and aorta of hamsters exposed to the cold and during hibernation and arousal. J. Histochem. Cytochem. 52, 603-615.
59. Schaffer, E. M., Liu, J. Z., Green, J., Dangler, C. A., and Milner, J. A. (1996). Garlic and associated allyl sulfur compounds inhibit N-methyl-N-nitrosourea induced rat mammary carcinogenesis. Cancer Lett. 102, 199-204.
60. Schlegel, N., and Waschke, J. (2009). VASP is involved in cAMP-mediated Rac 1 activation in microvascular endothelial cells. Am. J. Physiol. Cell Physiol. 296, C453-C462.
61. Schmidt, V. J., Wölfle, S. E., Boettcher, M., and de Wit C. (2008). Gap junctions synchronize vascular tone within the microcirculation. Pharmacol. Rep. 60, 68-74.
62. Shao, Q., Wang, H., McLachlan, E., Veitch,G. I., and Laird, D. W. (2005). Down-regulation of Cx43 by retro-viral delivery of small interfering RNA promotes an aggressive breast cancer cell phenotype. Cancer Res. 65, 2705-2711.
63. Shen, J., Wang, L. H., Zheng, L. R., Zhu, J. H., and Hu, S. J. (2010). Lovastatin inhibits gap junctional communication in cultured aortic smooth muscle cells. J. Cardiovasc. Pharmacol. Ther. 15, 296-302.
64. Solan, J. L., Fry, M. D. TenBroek, E. M., and Lampe, P. D. (2003). Con-nexin43 phosphorylation at S368 is acute during S and G2/M and in response to protein kinase C activation. J. Cell Sci. 116, 2203-2211.
65. Solan, J. L., and Lampe, P. D. (2007). Key connexin 43 phosphorylation events regulate the gap junction life cycle. J. Membr. Biol. 217, 35-41.
66. Touyz, R. M., and Schiffrin, E. L. (1997). Growth factors mediate intracellular signaling in vascular smooth muscle cells through protein kinase Clinked pathways. Hypertension 30, 1440-1447.
67. Trosko, J. E., and Ruch, R. J. (1998). Cell-cellcommunicationincarcino-genesis. Front. Biosci. 15, D208- D236.
68. Wade, M. H., Trosko, J. E., and Schindler, M. (1986). A fluorescence photobleaching assay of gap junction-mediated communication between human cells. Science 232, 525-528.
69. Wu, Y., Bond, M., Sala-Newby, G., and Newby, A. (2006). Altered S-phase kinase-associated protein-2 levels are a major mediator of cyclic nucleotide-induced inhibition of vascular smooth muscle cell proliferation. Circ. Res. 98, 1141-1150.
70. Xie, H., Laird, D. W., Chang, T. -H., and Hu, V. W. (1997). A mitosis-specific phosphorylation of the gap junction protein connexin43 in human vascular cells: Biochemical characterization and localization. J. Cell Biol. 137, 203-210.
71. Yamasaki, H., Krutovskikh, V., Mesnil, M., and Omori., andY. (1996). Con-nexin genes and cell growth control. Arch. Toxicol. 18, 105-114.
72. Yamasaki, H., and Naus, C. C. G. (1996). Role of connexin genes in growth control. Carcinogenesis 17, 1199-1213.
73. Yao, J., Hiramatsu, N., Zhu, Y., Morioka, T., Takeda, M., Oite, T., and Kita-mura, M. (2005). Nitric oxide-mediated regulation of connexin43 expression and gap junctional intercellular communication in mesan-gial cells. J. Am. Soc. Nephrol. 16, 58-67.
74. Yeh, H. I., Lupu, F., Dupont, E., and Severs, N. J. (1997). Upregulation of connexin43 gap junctions between smooth muscle cells after balloon catheter injury in the rat carotid artery. Arterioscler. Thromb. Vasc. Biol. 17, 3174-3184.
75. Yun, S. P., Ryu, J. M., Park, J. H., Kim, M. O., Lee, J. H., and Han, H. J. (2012). Prostaglandin E2 maintains mouse ESC undifferen-tiated state through regulation of connexin 31, -43 and -45 expression: Involvement of glycogen synthase kinase 3β/β-catenin. Biol. Cell. doi:10.1111/boc.201100032. [Epub ahead of print].
76. Zhang,W.,DeMattia,J.A.,Song,H.,and Couldwell, W. T. (2003). Communication between malignant glioma cells and vascular endothelial cells through gap junctions. J. Neurosurg. 98, 846-853.
77. Zhang, Y. W., Wen, J., Xiao, J. B., Tal-bot, S. G., Li, G. C., and Xu, M. (2006). Induction of apoptosis and transient increase of phosphorylated MAPKs by diallyl disulfide treatment in human nasopharyngeal carcinoma CNE2 cells. Arch. Pharm. Res. 29, 1125-1131.